




Ethiop. Vet. J., 2020, 24 (1), 116-126
Short Communication
Mycobacterium tuberculosis in a Primagam negative 
wild caught captive olive baboon (Papio anubis) in 
Ethiopia
Gizachew Gemechu1†, Sosina Ayalew1†, Elena Hailu1, Azeb Tarekegn1, Rea Tschopp*1,2,3
1Armauer Hansen Research Institute (AHRI), 1005 Jimma Road, Addis Ababa
2Swiss Tropical and Public Health Institute (Swiss TPH), 57 Socinsstr, 4002 Basel, Switzerland
3University of Basel, 4002 Basel, Switzerland
† Contributed equally to the study
*Corresponding author: Dr. Rea Tschopp, E-mail: rea.tschopp@swisstph.ch
Abstract
A free-roaming wild olive baboon (Papio anubis) was caught in the compound 
of a hospital and kept in captivity pending reintroduction to the wild. The ani-
mal had a sporadic dry cough but was TB negative on the blood-based assay 
PRIMAGAM (IFN-γ test). Six years later, the animal was found dead without 
any prior clinical signs. The lungs were severely affected. Laboratory analy-
sis included Ziehl-Neelsen staining, GenExpert, culture, deletion typing and 
spoligotyping.  M. tuberculosis was isolated. The spoligotype was SIT 53 (lin-
eage 4) and no Rifampicin resistance was detected. This case report raised 
challenges on accurate  diagnosis of TB in Non-Human Primates in Ethiopia, 
the question of latency in baboon and the lack of spread of a highly virulent TB 
strain in the Non-Human Primate colony. It also highlighted the potential role 
of TB transmission between Non-Human Primates and people in Ethiopia with 
impacts as well on public health as on primate conservation.  
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Introduction 
TB remains worldwide a leading cause for morbidity and mortality. Ethiopia 
has a high TB burden, ranking third in Africa and eighth globally among the 
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resistant TB (MDR-TB) has been increasingly observed in Ethiopia, with prev-
alence ranging from 3.3 and 46.3%, providing additional challenges to the na-
tional TB control program (Biadglegne et al., 2014). 
Non-human primates (NHP), like their human counterparts, can get infected 
with TB and show identical disease epidemiology (e.g. transmission, immunol-
ogy, type and course of disease) hence they are often used as model for hu-
man TB (Gormus et al., 2004; Scanga and Flyn 2014). Old world monkeys are 
considered to be the most susceptible species for TB among all NHP species 
(Montali et al., 2001). NHP are primarily affected by M. tuberculosis but M. bo-
vis infections have also been observed. The disease does not exist naturally in 
free-ranging NHP (Montali et al., 2001). However, TB becomes a major health 
risk for NHP when they are exposed to humans with TB (Fourie and Odendaal 
2003) or when they consume BTB infected meat (Tarara et al., 1985; Thorel et 
al., 1998; Keet et al., 2000). TB in captive NHP colonies has major health and 
economic implications (human exposure, animal losses, and cost for disease 
control and staff therapy) but also in terms of conservation (risk of TB to wild 
populations during reintroduction programs). Animals with active TB may be 
symptomless for weeks and months while they transmit the disease (Gibson 
1998). Latent TB, although not infectious can be reactivated at any time of the 
animal’s life. Latent TB is not detected by traditional screening methods such 
as the skin test (Lerche et al., 2008). Therefore, early TB detection in captive 
NHP is crucial. Unfortunately, there is currently no diagnostic gold standard 
test for TB. Traditionally, NHP are tested by skin test (eye-lid or abdominal 
skin PPD skin injections). This can be stressful for the animal, and requires 
two anesthesia within 72 hours. In addition, the skin test lacks specificity (84-
87%) and sensitivity (84%), does not always account for high environmental 
TB and does not detect latency (Garcia et al., 2004; Lerche et al., 2008; Lin et 
al., 2009). Rapid blood based in-vitro assay such as the PRIMAGAM test offer 
an alternative, with relatively good sensitivity (68%) and excellent specificity 
(97%) and able to detect TB at a very early stage (Garcia et al., 2004). PPD an-
tigens are presented to lymphocytes in whole blood culture and the resulting 
production of interferon-γ (IFN-γ) by the TB-exposed lymphocytes is detected 
using a monoclonal antibody-based sandwich enzyme immunoassay (EIA). 
Lymphocytes of non-infected animals does not produce any IFN-γ. We present 
here a case of M. tuberculosis detected in a captive wild caught olive baboon, 
who tested negative with the blood-assay TB-PRIMAGAM test and discuss the 
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Material and methods
History
A juvenile female olive baboon (Papio Anubis) was roaming freely on the prem-
ises of a large hospital in Addis Ababa, was then captured by the Ethiopian 
Wildlife and Conservation Authority and kept in captivity in a large enclosure 
close to Addis Ababa, Ethiopia before considering a potential release into the 
wild. Upon arrival, the animal underwent quarantine. She looked healthy with 
normal body condition. No visible clinical signs were observed with the excep-
tion of a very sporadic dry cough that would persist over the following years. 
The animal was housed with other rescued olive baboons. The large enclosure 
was on natural ground (shrubs, dirt ground, grass and rocks) surrounded by a 
meshed cage. Diet consisted on scattered mix of various fresh fruits and veg-
etables as well as supplemental grass and acacia tree branches with pods or 
flowers. All animals were screened shortly after arrival for tuberculosis (TB) 
using the commercially available primate interferon-γ test (Primagam® blood 
essay; Prionics AG). All tested animals were negative to the TB test. Six years 
later, the baboon was found dead in the enclosure without showing any prior 
signs of disease except a very sporadic dry cough that she kept throughout the 
years. 
Post-mortem examination
A standard post-mortem examination was carried out within 2 hrs. of death. 
Specimens of lung tissues were collected into sterile containers (one third with-
out transport media, which were frozen at -80°C, one third contained 10% for-
malin solution and one third contained PBS (phosphate buffered saline) and 
brought to the laboratory at the Armauer Hansen Research Institute (AHRI), 
Addis Ababa within 15 minutes of collection. 
Laboratory diagnosis
Suspicion of TB lead to follow all diagnostic procedures according to the in-
stitute and national TB SOP’s (TB program quality assurance) (e.g. use of 
P3-TB lab for all diagnostic procedures; wearing of face masks and gloves). 
Smears from lung tissue samples were prepared followed by Ziehl- Neelsen 
(ZN) staining and observation for acid fast bacilli under the light microscope. 
Mycobacterium culture was done on Lowenstein-Jensen (LJ) medium following 
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ratory Initiative, 2014). Tissue sample was homogenized with 3 ml phosphate 
buffered saline (PBS) using sterile mortar and pestle. Mycobacterium culture 
was done on Lowenstein-Jensen (LJ) medium. Digestion-decontamination of 
tissue sample was performed by N-acetyl L-cysteine /Sodium Hydroxide meth-
od (NALC/NAOH) with a final NaOH concentration of 1%.  An equal volume 
of standard NALC/NaOH solution was added to tissue sample and incubated 
for 15 minutes. After neutralization by PBS and centrifugation (15 minutes 
at 3000g), the sediment was re-suspended in 1ml sterile PBS. Finally, 200μl 
of sediment was used to inoculate on two LJ slants. The remaining sediment 
was used for smear preparation followed by Ziehl- Neelsen (ZN) staining, and 
examined for acid-fast bacilli (AFB) using regular light microscopy (Federal 
Democratic Republic Ethiopia Ministry of Health, 2014). The AFB grading was 
done according to WHO smear grading scale for ZN staining (WHO, 1998). 
Culture was checked daily during the first week, then weekly thereafter. Colo-
nies from positive culture were removed from the surface of LJ medium and 
suspended in 300 μl of Molecular grade water and the mixture heated at 80°C 
for 1 hr. in water bath. After centrifugation, the supernatant was collected and 
used for RD9 deletion typing and spoligotyping.   
RD 9 Deletion Typing 
Mycobacterial species was identified using polymerase chain reaction (PCR) 
based region of difference (RD9) typing as described by Brosch et al. (2002) 
using previously published RD9_FlankF, IntR and FlankR primer sequence 
(Berg et al., 2009). PCR was performed on heat-killed cells. M. tuberculosis 
H37Rv, M. bovis, and Qiagen water was used respectively as positive and neg-
ative controls.
Spoligotyping
Spoligotyping was performed following the method described by Kamerbeek et 
al. (1997).The spoligotype pattern was entered in an Excel spreadsheet, com-
pared with those in the International Spoligotyping Database (SITVITWEB) of 
the Pasteur Institute of Guadaloupe (http://www.pasteur-guadeloupe.fr:8081/
SITVIT_ONLINE/), and a spoligotype international type (SIT) was assigned.
 
In addition, for the sake of diagnostic speed, 0.5 ml of homogenized tissue 
sample was subjected for GeneExpert analysis by mixing with the supplied 
sample reagent in a 1:3 ratio, vortexed and incubated for 15 minutes. Two ml 
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pasteur pipette and the cartridge loaded onto Expert machine. The GeneXpert 
automates all following steps, including sample work-up, nucleic acid ampli-
fication, detection of the target sequence and result interpretation (Geleta et 
al., 2015). 
Further investigation of personnel
Four primate animal personnel, who had close physical contact to the TB posi-
tive animal over the years but showed no clinical signs of TB, wished to be 
tested for TB as well following the result of the animal. The gamma interferon 
test (QuantiFERON-TB Gold Plus) was used. Four ml of venous blood was 
drawn into lithium-heparin tubes and processed within 2 hours at AHRI. One 
ml of blood was dispensed into each QFT plus tubes (Nil, TB1, TB2, mitogen) 
followed by mixing by inversion and incubation at 37°C for 20 hrs. After in-
cubation, the tubes were centrifuged at 3000 RPM for 10 minutes, the super-
natants removed and the amount of IFN gamma measured by ELISA. IFN-γ 
ELISA was performed according to the QFT-Plus protocol and the result was 
interpreted using the software supplied by the manufacturer. 
Results
The animal showed a normal to thin body condition based on the body scor-
ing system by Clingerman and Summers (2005). No external changes were 
observed with the exception of hyperaemic conjunctivae. Superficial lymph 
nodes were normal. Intra-abdominal examination showed that all organs were 
hyperaemic without other visible pathological abnormalities. Lungs were se-
verely enlarged and abnormally shaped, having entirely lost their normal lung 
shape, with hard bumpy sections and ballooning. The lungs filled the entire 
thorax cavity with fibrous adhesions to the pleura that made extraction from 
the thorax cavity difficult. The lungs were removed en-toto using sharp and 
blunt dissection. The lung texture was hard fleshy for most part of the organ 
with hardly any normal looking lung tissue left. Granulomas, soft in texture 
could be felt throughout the lungs. Upon dissection, the lungs were entirely 
filled with various sized cavities (from 1 to 5 cm in diameters) sometimes co-
alescent/confluent filled with little liquid creamy looking pus and ill-defined 
walls (Figure 1). When pressure was applied to the lungs, pus would ooze out 
from everywhere, including bronchi. No calcifications were observed. Lung 
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Ziehl-Neelsen staining of three slides (direct lung smear) and one slide with 
colonies from culture were graded as +++, implying the presence of more than 
10 Acid Fast Bacilli per field. The result of the GenExpert was positive for M. 
tuberculosis and no rifampicin resistance was detected. Results from culture 
showed colony growth within two weeks of inoculation that were creamy white 
dry, rough, raised, irregular with wrinkled surface and confluent growth was 
observed.  Figure 2 shows the results of RD9 deletion typing. The isolate had 
an intact RD 9 region identifying it as M. tuberculosis. The spoligo pattern was 
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Figure 2. Electrophoretic pattern of the amplified element of PCR products, 
Lane=100bp ladder; Lane 2= H37Rv (M. tuberculosis positive control), Lane 3= 
Qiagen H2O (negative control); Lane 4 = M. bovis (positive control); Lane 5= 
DNA from heat killed culture 
Human samples
One out of 4 people were positive to the quantiferon test, hence making M. 
tuberculosis infection likely. However, due to the limitation of the test, defini-
tive diagnosis of whether the infection is active or most probably latent since 
the person did not show any signs of active TB, requires further combination 
of epidemiological, historical, medical and complementary diagnostic findings. 
Furthermore, the study could not link with certainty the infection in the ani-
mal and the person due to the lack of M. tuberculosis isolation in the sampled 
people. 
Discussion 
This case-study highlighted two major issues regarding TB in NPH, namely: 1) 
poor detection of TB by the blood-based assay PRIMAGAM and 2) the unusual 
very long disease course and lack of further spread. In hindsight, we assume 
that the animal had likely already an active TB, when he was tested 6 years 
ago considering the chronic cough she had. Animals with active TB can be 
symptomless for weeks to months (Gibson, 1998). However, although TB can 
be a chronic debilitating disease, having an active TB for so many years has, 
to our knowledge not been observed. Furthermore, the animal kept his good 
body condition to the end and no disease outbreak occurred in the colony. TB 
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underwent monthly health checks during these 6 years (assessment of body 
condition, cough, appetite etc). Furthermore, autopsies were performed as a 
standard procedure on several NHP during these 6 years that died from any 
cause. No visible lesions suggestive for TB were ever observed, and smears of 
samples collected routinely from autopsies were ZN negative. In addition we 
know that the isolated strain belonged to a virulent most commonly found lin-
eage in Ethiopia (modern lineage), which makes it more surprising for not hav-
ing spread fast. It is well possible that the animal was already in an advanced 
state of anergy during the testing. However, it would be unlikely she would 
have survived another 6 years. TB latency is a growing concern in the NHP 
TB epidemiology. Studies have shown that a latent TB can be reactivated for 
example by a pregnancy and develop quickly into a fatal active TB (Martino et 
al., 2006).  Hence, the importance to diagnose TB at the latent stage. The last 
possibility is that the animal was negative at the time of the testing and it ac-
quired the disease while in captivity. However, this scenario is the least plau-
sible since no other baboons sharing the enclosure became clinically sick with 
TB, and later performed autopsies did not reveal any visible TB-like lesions 
and were ZN negative. A TB latency could not to be ruled out in the remaining 
animals of the group, However, latency over several years in a captive primate 
colony has never been previously described. 
The standard testing procedure in NHP remains the Tuberculin Skin test-
ing (TST), which detects delayed type hypersensitivity (DTH) to tuberculin 
antigens. Classically, the SIDT test is performed in the eyelid and swellings 
observed after 72 hours. The procedure requests two anesthesia and is subject 
to the observer’s interpretation leading to subjectivity. The required antigen 
concentration to detect reactivity for TB is higher than in humans but the 
exact quantity of tuberculin units (TU) is often not provided in PPD for NHP 
and same testing is often used as in humans. The TST is known for its poor 
sensitivity and specificity and leads to false negative animals (Lerche et al., 
2008). Moreover, the TST does not detect TB latency. Various blood tests have 
been used to screen NHP with diverse results (Parsons et al., 2004; Vervenne 
et al., 2004). More recently, non-invasive TB screening was done among chim-
panzees and baboons in Tanzania, using fecal IS6110 PCR (Wolf et al., 2016). 
Blood tests, such as the PRIMAGAM, reduces the stress in animals since only 
one anesthesia is required. Unlike the TST, it is a quantifiable test. It detects 
TB reactivity by measuring the IFN-γ production by lymphocytes that had 
contact to Mycobacteria. It is highly specific (97%) and can detect TB at a very 
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single test has the high enough sensitivity and specificity to detect correctly 
all positive animals in a group and a combination of tests might be necessary, 
highlighting the still existing challenge to diagnose accurately TB. 
TB in NHP is a concern in Ethiopia in light of the high numbers of illegally 
kept primates with close contact to humans, rehabilitated/rescued primates 
that are set to be released into the wild and the many free-ranging NHP in 
close vicinity to human dwellings, particularly urban wild NHP. The baboon of 
this study was a wild baboon initially roaming freely in a hospital compound. 
In light of the high TB burden in Ethiopia and the emergence of MDR-TB, 
these wild roaming NHPs can become infected by TB and can then also poten-
tially act as vehicle for further spread to humans and other NHP. Awareness 
campaigns are warranted. They are a crucial step in controlling the spread of 
TB between humans and NHP but also for overall conservation purposes, by 
promoting the stop of illegal ownership of NHP as pets and banning illegal 
wildlife trade.
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